Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
BFNHBioforce Nanosciences Holdings, Inc.
Filed Aug 7, 2024 · 10-Q · 38 days after period end · 0001091818-24-000085
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | -$114.44K | -$113.93K | -$115.78K | -$122.32K |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 7, 2024 · 38 d after period end
